MX2010004265A - Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. - Google Patents
Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo.Info
- Publication number
- MX2010004265A MX2010004265A MX2010004265A MX2010004265A MX2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A
- Authority
- MX
- Mexico
- Prior art keywords
- active ingredient
- administering
- composition
- making
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Abstract
En la presente se proporcionan composiciones para administrar oralmente o en forma transmucosal un ingrediente activo, que tienen una capa de película, un revestimiento aplicado en por lo menos un lado de la capa de película, y un ingrediente activo en la capa de película, en revestimiento, o en ambas capas; en ciertas modalidades la composición también incluye un compuesto efervescente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98138907P | 2007-10-19 | 2007-10-19 | |
PCT/US2008/080362 WO2009052421A1 (en) | 2007-10-19 | 2008-10-17 | Composition for administering an active ingredient and method for making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004265A true MX2010004265A (es) | 2010-07-28 |
Family
ID=40567804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004265A MX2010004265A (es) | 2007-10-19 | 2008-10-17 | Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2214478A1 (es) |
CA (1) | CA2702614A1 (es) |
MX (1) | MX2010004265A (es) |
WO (1) | WO2009052421A1 (es) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8731673B2 (en) | 2007-02-26 | 2014-05-20 | Sapiens Steering Brain Stimulation B.V. | Neural interface system |
US20100178254A1 (en) * | 2009-01-13 | 2010-07-15 | Monosol Rx Llc | Unit assembly for multiple film dosages, apparatus, and methods |
US20100291160A1 (en) * | 2009-05-13 | 2010-11-18 | Carver David R | Pharmaceutical system for trans-membrane delivery |
ES2554626T3 (es) | 2009-06-12 | 2015-12-22 | Cynapsus Therapeutics Inc. | Apomorfina sublingual |
US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
US20180110724A1 (en) * | 2009-12-08 | 2018-04-26 | Intelgenx Corp. | Film dosage form with multimodal and particle size distributions |
US20110263606A1 (en) * | 2010-04-26 | 2011-10-27 | Horst Zerbe | Solid oral dosage forms comprising tadalafil |
WO2012053006A2 (en) | 2010-10-18 | 2012-04-26 | Panacea Biotec Ltd | Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
DE102010049708A1 (de) | 2010-10-28 | 2012-05-03 | Hexal Ag | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
KR102025238B1 (ko) | 2010-12-16 | 2019-09-25 | 선오비온 파마슈티컬스 인코포레이티드 | 설하 필름 |
US10687975B2 (en) * | 2011-02-04 | 2020-06-23 | Joseph E. Kovarik | Method and system to facilitate the growth of desired bacteria in a human's mouth |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
US11523934B2 (en) | 2011-02-04 | 2022-12-13 | Seed Health, Inc. | Method and system to facilitate the growth of desired bacteria in a human's mouth |
US10562281B2 (en) | 2011-08-02 | 2020-02-18 | Kimberly-Clark Worldwide, Inc. | Cooling signal device for use in an absorbent article |
EP2594257A1 (en) * | 2011-11-17 | 2013-05-22 | Labtec GmbH | Orodispersible films for the manufacturing of individualised medicine or for large scale production |
WO2013023775A1 (en) * | 2011-08-12 | 2013-02-21 | Labtec Gmbh | Orodispersible films for the manufacturing of individualised medicine or for large scale production |
WO2014092661A1 (en) * | 2012-01-18 | 2014-06-19 | Mahmut Bilgic | Particulate formulations of tadalafil in effervescent form |
WO2015073573A1 (en) * | 2013-11-14 | 2015-05-21 | Jacobs Michael M | Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
NZ735777A (en) | 2015-03-26 | 2023-03-31 | Jacqueline M Iversen | Methods and compositions to inhibit symptoms associated with veisalgia |
CA3127926A1 (en) | 2015-04-21 | 2016-10-27 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
US9855227B2 (en) | 2015-12-18 | 2018-01-02 | The Procter & Gamble Company | Quick dissolving diphenhydramine oral dosage form |
EP3452023A1 (en) | 2016-05-05 | 2019-03-13 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
FR3058871A1 (fr) * | 2016-11-18 | 2018-05-25 | Adnane Remmal | Composition stable solide a base de compose aromatique et utilisations |
US20200281889A1 (en) * | 2019-03-07 | 2020-09-10 | Terpene Therapeutics Inc. | Edible Film Comprising Adjacent Conjoined Strips |
EP3989909A1 (en) | 2019-06-27 | 2022-05-04 | Sunovion Pharmaceuticals Inc. | Child-resistant dispensers for thin strip medications |
US20230338320A1 (en) | 2019-11-22 | 2023-10-26 | Wockhardt Limited | Oral film composition comprising levothyroxine |
US11179331B1 (en) | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
AU2021280285A1 (en) * | 2020-05-26 | 2023-02-02 | Strategic Drug Solutions, Inc. | Formulations and methods for treating erectile dysfunction |
DE102021100718A1 (de) | 2021-01-15 | 2022-07-21 | Lts Lohmann Therapie-Systeme Ag. | Aufgestreute Rückschicht |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010006677A1 (en) * | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
US8765167B2 (en) * | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
CA2505833A1 (en) * | 2002-11-14 | 2004-06-03 | Innozen, Inc. | Edible film for relief of cough or symptoms associated with pharyngitis |
US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
WO2006119286A1 (en) * | 2005-05-03 | 2006-11-09 | Innozen, Inc. | Edible film for transmucosal delivery of nutritional supplements |
-
2008
- 2008-10-17 WO PCT/US2008/080362 patent/WO2009052421A1/en active Application Filing
- 2008-10-17 CA CA2702614A patent/CA2702614A1/en not_active Abandoned
- 2008-10-17 MX MX2010004265A patent/MX2010004265A/es not_active Application Discontinuation
- 2008-10-17 EP EP08838844A patent/EP2214478A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2214478A1 (en) | 2010-08-11 |
CA2702614A1 (en) | 2009-04-23 |
WO2009052421A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004265A (es) | Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. | |
MX2009007254A (es) | Composiciones de tableta en tableta. | |
MY152985A (en) | Cosmetic or pharmaceutical composition, to be applied topically | |
WO2007081835A3 (en) | Modulators of hypoxia inducible factor-1 and related uses | |
WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
WO2007132296A3 (en) | Multilayer tablet | |
WO2006023444A3 (en) | Anti-adhesion barrier | |
WO2009147402A3 (en) | Compositions comprising honey and a super- absorbent material | |
CA2713555C (en) | Topical compositions and methods for whitening skin | |
RS54904B1 (sr) | Antibakterijske farmaceutske kompozicije | |
TW200600111A (en) | Improved dental whitening method | |
TW200745413A (en) | Method of forming a vapor impermeable, repulpable coating for a cellulosic substrate and a coating composition for the same | |
WO2012027065A3 (en) | Combination therapy for treatment of disease | |
MX2009002183A (es) | Composiciones de pelicula en capas, empaques preparados a partir de las mismas y metodos de uso. | |
WO2008092006A3 (en) | Antimicrobial compositions | |
ATE509856T1 (de) | Verpackung für wirkstoffhaltige filme und verfahren für deren herstellung | |
MY158687A (en) | Micro-needle device and preparation method | |
WO2007064885A3 (en) | Oral care compositions, methods, devices and systems | |
WO2008002529A3 (en) | Orally disintegrating layered compositions | |
HK1132175A1 (en) | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity | |
WO2008085570A3 (en) | Flux formulations | |
WO2007130841A3 (en) | Oral compositions comprising siloxane polymers | |
MY158832A (en) | Multilayer films for delivery of flavor | |
GB201009426D0 (en) | Tapes comprising barrier coating compositions and components comprising the same | |
WO2010066639A3 (en) | Skin lightening compositions with acetylcholinesterase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |